Cellceutix Garners $1,000,000 New Financing

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    100 Cumming Center Beverly, MA 01915
  • Company Description
    Cellceutix Corporation is an emerging bio-pharmaceutical company in the business of developing small molecule therapies in areas of unmet medical need. Our primary efforts are in cancer and inflammatory disease. We intend to spend most of our time initially on our lead product, Kevetrin, which is being developed for drug-resistant cancers.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor

By posting a comment, you agree to our terms and conditions.